BMRN vs GENVR
Biomarin Pharmaceutical Inc (BMRN) versus Gen Digital Inc. Contingent Value Rights (GENVR) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Gen Digital Inc. Contingent Value Rights (GENVR) common stock listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
GENVR does not have a complete income-statement cache yet.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. GENVR currently screens at market cap $0.
Not investment advice. Open the BMRN and GENVR stock pages for the full models.
Not investment advice.